Notice of Change to Application Due Date for RFA-CA-23-025 "Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required)"
Notice Number:
NOT-CA-23-051

Key Dates

Release Date:

March 21, 2023

Related Announcements

RFA-CA-23-025 - Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to change the Application Due date for RFA-CA-23-025  "Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required)".

Part 1. Overview Information, Key Dates

Currently, it reads:


Open Date (Earliest Submission Date): May 30, 2023
Letter of Intent Due Date(s): 30 days prior to application due date.

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDSScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
June 30, 2023Not ApplicableNot ApplicableOctober 2023January 2024April 2024

Expiration Date: July 1, 2023

Revised to read (in bold italics):


Open Date (Earliest Submission Date): June 24, 2023
Letter of Intent Due Date(s): 30 days prior to application due date.

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDSScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
July 24, 2023Not ApplicableNot ApplicableOctober 2023January 2024April 2024

Expiration Date: July 25, 2023

All other aspects of RFA-CA-23-025 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Michelle Mollica, PhD, MPH, RN, OCN
National Cancer Institute (NCI)
Telephone: 240-276-7621
Email: michelle.mollica@nih.gov

Peer Review Contact(s)

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov

Financial/Grants Management Contact(s)

Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 301-496-8634
Email: wolfreyc@mail.nih.gov